Welcome to our dedicated page for DONALDSON Co SEC filings (Ticker: DCI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on DONALDSON Co's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into DONALDSON Co's regulatory disclosures and financial reporting.
Donaldson Company director Trudy Rautio reported acquiring additional company equity. On January 2, 2026, she acquired 900 shares of common stock at a stated price of $0 per share and 311 shares of common stock at $89.93 per share. After these transactions, she beneficially owned 27,235 shares of Donaldson common stock held directly. The same day, she was also granted a stock option for 3,000 shares of Donaldson common stock at an exercise price of $89.93 per share, expiring on January 2, 2036. The option vests in three equal annual installments beginning January 2, 2027.
Donaldson Company director equity update: A director of Donaldson Co Inc (DCI) reported new equity awards effective 01/02/2026. The filing shows an acquisition of 900 shares of common stock at a reported price of $0, bringing the director’s directly held common stock to 44,997 shares. The director also received a stock option covering 3,000 shares with an exercise price of $89.93 per share, expiring on 01/02/2036. The option vests in three equal annual installments beginning on January 2, 2027, which spreads the potential ownership increase over several years.
Donaldson Company director James J. Owens reported new equity awards and share acquisitions. On January 2, 2026, he acquired 900 shares of Donaldson common stock at a reported price of $0 per share and an additional 250 shares at $89.93 per share. Following these transactions, he directly beneficially owned 22,215 shares of common stock.
Owens also received a stock option giving him the right to buy 3,000 Donaldson shares at an exercise price of $89.93 per share, expiring on January 2, 2036. The option vests in three equal annual installments beginning on January 2, 2027, which means the right to exercise the option phases in over three years.
Donaldson Company director Richard M. Olson reported new equity awards in the company’s stock. On January 2, 2026, he acquired 900 shares of common stock at a price of $0, bringing his directly held stake to 6,090 shares after the transaction.
On the same date, Olson also received a stock option grant for 3,000 shares with an exercise price of $89.93 per share, expiring on January 2, 2036. The option vests in three equal annual installments beginning January 2, 2027, meaning the right to buy these shares becomes available gradually over three years.
Donaldson Co Inc director reports stock and option awards
A director of Donaldson Co Inc reported receiving 900 shares of common stock on 01/02/2026 at a stated price of $0. After this transaction, the director beneficially owns 2,473 common shares directly and 12,592 common shares indirectly through a trust where the director and spouse serve as trustees and beneficiaries.
The director was also granted a stock option to buy 3,000 shares of common stock at an exercise price of $89.93 per share on 01/02/2026. This option expires on 01/02/2036 and vests in three equal annual installments beginning January 2, 2027. All reported holdings are listed as beneficially owned following these awards.
Donaldson Company director insider transactions disclosed
Director Christopher M. Hilger reported acquiring Donaldson Company common stock and stock options on January 2, 2026. He acquired 375 shares of common stock at $89.93 per share and 900 shares at $0, and held 15,342 shares directly after these transactions.
Hilger was also granted a stock option for 3,000 shares of common stock at an exercise price of $89.93 per share, expiring on January 2, 2036. The option vests in three equal annual installments beginning on January 2, 2027, and he held 3,000 derivative securities directly after the reported transaction.
Donaldson Company director reports stock and option awards
A director of Donaldson Co Inc reported receiving 900 shares of common stock on January 2, 2026 at a stated price of $0, bringing the director's directly held stake to 16,747 common shares. On the same date, the director was granted a stock option for 3,000 shares of common stock with an exercise price of $89.93 per share and no separate option purchase price.
The option covers 3,000 underlying common shares, becomes exercisable in three equal annual installments starting January 2, 2027, and carries an expiration date of January 2, 2036. All reported holdings and awards are listed as directly owned by the reporting person.
An insider of issuer DCI has filed to sell common shares under Rule 144. The notice covers the planned sale of 11,000 common shares through Morgan Stanley Smith Barney LLC on or about 01/02/2026 on the NYSE, with an aggregate market value of 988,049.70. The shares were acquired on 01/02/2026 by exercising options under a registered plan, with cash payment made on 12/30/2025. The issuer reports 115,336,687 shares of this class outstanding.
Donaldson Company director reports new stock and option awards. Director Daniel P. Shine acquired 100 shares of Donaldson Company common stock on December 8, 2025, reported at a price of $0, bringing his directly held common shares to 100 after the transaction. On the same date, he was also granted a stock option to buy 200 shares of common stock at an exercise price of $91.76 per share, expiring on December 8, 2035.
The option vests in three equal annual installments beginning on December 8, 2026, meaning the right to exercise is spread over three years. Following these awards, Shine directly holds 200 stock options in addition to the 100 common shares.
Donaldson Company’s chief financial officer reported routine equity transactions in company stock. On 12/09/2025, the officer exercised 1,000 employee stock options at an exercise price of $28 per share, receiving an equal number of common shares. That same day, the officer sold 566 shares of Donaldson common stock at a price of $91.57 per share.
Following these transactions, the officer directly owned 434 shares of Donaldson common stock and also held additional shares indirectly through a benefit plan trust, as noted in the filing. The filing is a standard Form 4, which discloses changes in ownership by company insiders so investors can see how key executives are managing their personal stakes.